Abstract
Recently, the Antibody Development Center at the Butantan Institute began implementing the Center of Nanobody Discovery, led by researchers Daniela Luz, Debora Moretti and Roxane Piazza. This center aims to implement a platform for the selection of therapeutic nanobodies and detection against different antigens, from poisons to infectious and tumor targets with the purpose of generating m…